Large-scale testing (Phase 3)Study completedNCT00240305
What this trial is testing
Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
Who this might be right for
Metabolic SyndromeDyslipidemia
AstraZeneca 15